1-83906450-C-T
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong
The NM_024686.6(TTLL7):c.2006G>A(p.Arg669Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000098 in 1,611,700 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R669W) has been classified as Uncertain significance.
Frequency
Consequence
NM_024686.6 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000922 AC: 14AN: 151902Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000104 AC: 26AN: 250024 AF XY: 0.000104 show subpopulations
GnomAD4 exome AF: 0.0000987 AC: 144AN: 1459680Hom.: 0 Cov.: 31 AF XY: 0.000110 AC XY: 80AN XY: 726150 show subpopulations
GnomAD4 genome AF: 0.0000921 AC: 14AN: 152020Hom.: 0 Cov.: 32 AF XY: 0.0000673 AC XY: 5AN XY: 74288 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.2006G>A (p.R669Q) alteration is located in exon 17 (coding exon 16) of the TTLL7 gene. This alteration results from a G to A substitution at nucleotide position 2006, causing the arginine (R) at amino acid position 669 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at